Dermatomyositis and Small Cell Lung Cancer: Risks, Treatment, and More Health ConditionsFeaturedBreast CancerIBD MigraineMultiple Sclerosis (MS)Rheumatoid ArthritisType 2 DiabetesSponsored TopicsArticlesAcid RefluxADHDAllergiesAlzheimer's & DementiaBipolar DisorderCancerCrohn's DiseaseChronic PainCold & FluCOPDDepressionFibromyalgiaHeart DiseaseHigh CholesterolHIVHypertensionIPFOsteoarthritisPsoriasisSkin Disorders and CareSTDsDiscoverWellness TopicsNutritionFitnessSkin CareSexual HealthWomen's HealthMental HealthSleepOriginal SeriesFresh Food FastDiagnosis DiariesYou’re Not AlonePresent TenseVideo SeriesYouth in FocusHealthy HarvestNo More SilenceFuture of HealthPlanHealth ChallengesMindful EatingSugar SavvyMove Your BodyGut HealthMood FoodsAlign Your SpineFind CarePrimary CareMental HealthOB-GYNDermatologistsNeurologistsCardiologistsOrthopedistsLifestyle QuizzesWeight ManagementAm I Depressed? A Quiz for TeensAre You a Workaholic?How Well Do You Sleep?Tools & ResourcesHealth NewsFind a DietFind Healthy SnacksDrugs A-ZHealth A-ZConnectFind Your Bezzy CommunityBreast CancerInflammatory Bowel DiseasePsoriatic ArthritisMigraineMultiple SclerosisPsoriasisFollow us on social mediaShopProducts by ConditionInsomniaStress ReliefBack PainNeck PainSleep ApneaHot SleepersAllergiesPain ReliefProduct ReviewsVitamins & SupplementsSleepMental HealthNutritionAt-Home TestingCBDMen’s HealthWomen’s HealthHealth ConditionsDiscoverPlanConnectShopSubscribe

Dermatomyositis and Small Cell Lung Cancer

Medically reviewed by Adithya Cattamanchi, M.D., Pulmonology — By Jill Seladi-Schulman, Ph.D. on October 20, 2022Dermatomyositis is an inflammatory disease that mainly affects the muscles and skin. While there’s no cure for dermatomyositis, the condition can be managed through measures like medications and physical therapy. Having dermatomyositis is associated with various complications and risks. One of these is an increased likelihood of developing cancers, including small cell lung cancer (SCLC). In this article, we take a closer look at dermatomyositis, its association with SCLC, and more.

What is dermatomyositis

Dermatomyositis (DM) is a type of condition called an inflammatory myopathy, which is marked by muscle inflammation and weakness. It’s believed to be an autoimmune disease, which is when the immune system attacks healthy tissues. What causes DM is unknown, but is thought to be a combination of genetic and environmental factors. What we do know is that DM is very rare. It’s estimated to occur in only 9.63 out of 1 million people.

Symptoms of dermatomyositis

One of the main symptoms of DM is muscle weakness. This tends to get worse over time and most often affects muscles close to your core, such as those of the neck, shoulders and upper arms, and hips. As it worsens, muscle weakness can begin to impact certain movements, such as walking, climbing stairs, or lifting your arms over your head. When muscles in the neck are affected, it can lead to trouble talking or swallowing. In addition to muscle symptoms, people with DM also have a variety of skin symptoms, including:specific types of skin rashes, such as heliotrope rashlight sensitivityskin pigmentation changesitching Other potential symptoms of DM include:muscle painjoint pain or swellingnail changesrespiratory symptoms like cough or shortness of breathfatiguefeverunintentional weight loss

Can dermatomyositis cause small cell lung cancer

People with DM are estimated to have a 6-fold higher risk of developing cancer compared with the general population. In fact, it’s estimated that 10% to 25% of DM cases are associated with cancer. Cancer is often diagnosed at the same time as DM or shortly after. The risk is highest in the first year after a DM diagnosis and continues to be so for up to 5 years. However, even after this, people with DM still have a high cancer risk compared with the general population. Lung cancer is often linked with DM. A small older study found that the most common type of lung cancer associated with DM was SCLC. SCLC is one of two main types of lung cancer, making up about 10% to 15% of all lung cancers. It often grows and spreads faster than non-small cell lung cancer (NSCLC), the other main type of lung cancer.

What s the link between dermatomyositis and small cell lung cancer

The exact cause-and-effect link between DM and cancer, including SCLC, isn’t fully understood. Some experts believe that DM is a type of paraneoplastic syndrome. Paraneoplastic syndromes often happen when there’s a dysfunctional immune response to a tumor. They can also occur when a tumor produces a hormone or other peptide. Here’s an example of how that might happen with DM:DM is associated with the presence of various antibodies that attack healthy tissue. One of these is an antibody against TIF1-gamma. This antibody targets markers that are mainly present in the muscles and skin.Normally, the TIF1-gamma protein in your body is a tumor suppressor, meaning it’s involved in inhibiting cell growth. However, when it becomes mutated it can mean that cells are free to grow and divide out of control.It’s possible that antibodies to mutated TIF1-gamma proteins in cancer cells could cross-react with normal TIF1-gamma proteins in the muscles and skin, leading to DM. This could explain why DM and cancer often happen so closely together.Anti-TIF1-gamma antibodies are associated with the development of cancer in DM. In fact, up to 84% of people with anti-TIF1-gamma antibodies have DM that’s associated with cancer.

What other cancers are linked to dermatomyositis

In addition to SCLC, DM is linked to several other types of cancer. These include:other types of lung cancer, such as NSCLCovarian cancerstomach cancerpancreatic cancerbreast cancercervical cancerbladder cancercolorectal cancernasopharyngeal cancerlymphoma Some factors may increase the risk of cancer for people with DM. These include:being 45 years and older at DM diagnosis being assigned male at birthexperiencing severe DM symptomshaving trouble swallowing as a DM symptomhaving anti-TIF1-gamma antibodieshaving DM that’s resistant to standard treatments

How does dermatomyositis affect treatment for small cell lung cancer

DM itself is often treated with corticosteroids. These are drugs that reduce the level of inflammation in the body. If necessary, other immunosuppressants like methotrexate and azathioprine may also be used for DM. These types of immunosuppressants broadly dampen the immune response. In situations where DM and SCLC occur together, DM may be treated briefly first. Then cancer treatment for SCLC is started, which typically includes one or a combination of surgery, chemotherapy, or radiation therapy. A 2022 case study also found that chemotherapy with the immunotherapy drug atezolizumab (Tecentriq) may be beneficial for DM-associated SCLC with anti-TIF1-gamma antibodies. After treatment, symptoms improved and tumor size decreased.

How does dermatomyositis affect the outlook of those with small cell lung cancer

The outlook for DM and cancer is generally poor. A 2019 study notes that lung cancer signs in people with DM may be nonspecific and overlooked. Due to this, cancer may be diagnosed at more advanced stages when it has spread and is more difficult to treat. A 2020 study notes that previous research has found that the 5-year survival rate of people with DM is between 60% and 90%. When DM is associated with cancer, this falls to between 10% and 56%. Because DM and cancer can be closely linked, treating the cancer can reduce DM symptoms in some situations. For example, a 2021 case study reports resolution of DM symptoms after chemotherapy and radiation treatment for SCLC. However, even if DM symptoms resolve, it doesn’t mean that the cancer will go away as well. SCLC is often more aggressive than other types of lung cancer. According to the American Cancer Society (ACS), the 5-year survival rates are:29% for SCLC that remains localized to the lung18% for SCLC that’s spread to nearby tissues or lymph nodes3% for SCLC that’s spread to more distant tissues (metastasized)7% overall Besides the type of cancer and health conditions like DM, other factors are important for outlook as well, such as the cancer’s stage, grade, and your age. Your care team can provide you with a better estimate of your individual outlook.

Takeaway

Dermatomyositis (DM) is a condition that happens when your immune system mistakenly attacks your muscles and skin. It’s also associated with an increased risk of cancer, including lung cancers like SCLC. The exact connection between DM and cancers like SCLC is unknown. However, it’s possible that a dysfunctional immune response to cancerous changes contributes to the link between the two conditions. Overall, the outlook for SCLC and DM is poor. However, it’s important to talk with your healthcare team regarding individual treatment recommendations and outlook. Last medically reviewed on October 20, 2022

How we vetted this article

SourcesHistoryHealthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.Arnon J, et al. (2021). SCLC, paraneoplastic dermatomyositis, positive transcription intermediary factor 1-γ, and point mutation in the transcription intermediary factor 1-γ coding gene: A case report.
sciencedirect.com/science/article/pii/S266636432100076XChang LMM, et al. (2020). Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.
journals.lww.com/md-journal/fulltext/2020/08210/malignancy_in_dermatomyositis__a_retrospective.48.aspxDermatomyositis. (2018).
rarediseases.org/rare-diseases/dermatomyositis/De Vooght J, et al. (2019). Anti-TIF1-gamma autoantibodies: Warning lights of a tumor autoantigen.
academic.oup.com/rheumatology/article/59/3/469/5688954Fujita J, et al. (2001). Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature [Abstract].
pubmed.ncbi.nlm.nih.gov/11269538/Hu T, et al. (2019). Dermatomyositis and malignancy.
ncbi.nlm.nih.gov/pmc/articles/PMC6738379/Kim Y, et al (2022). Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-gamma antibody-positive dermatomyositis: A case report.
onlinelibrary.wiley.com/doi/full/10.1111/1759-7714.14609Lu X, et al. (2014). Factors predicting malignancy in patients with polymyositis and dermatomyostis: A systematic review and meta-analysis.
ncbi.nlm.nih.gov/pmc/articles/PMC3979740/Lung cancer survival rates. (2022).
cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.htmlNikolaos T, et al. (2013). Dermatomyositis as an early manifestation and a significant clinical precursor of lung cancer: Report of a rare case and review of the current literature.
ncbi.nlm.nih.gov/pmc/articles/PMC3560494/Papakonstantinou E, et al. (2016). A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: A case report.
jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-016-0816-8Paraneoplastic syndromes. (n.d.).
ninds.nih.gov/health-information/disorders/paraneoplastic-syndromesQin Y-Y, et al. (2017). Case report: Dermatomyositis associated with lung cancer with heterogeneous morphology.
ncbi.nlm.nih.gov/pmc/articles/PMC5756961/Qudsiya Z, et al. (2022). Dermatomyositis.
ncbi.nlm.nih.gov/books/NBK558917/Sato Y, et al. (2022). Development of dermatomyositis after anti-transcriptional intermediary 1-gamma antibody seroconversion during treatment for small cell lung cancer.
bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-022-01974-4Treatment choices for small cell lung cancer, by stage. (2021).
cancer.org/cancer/lung-cancer/treating-small-cell/by-stage.htmlWhat is lung cancer? (2019).
cancer.org/cancer/lung-cancer/about/what-is.htmlZhang T, et al. (2019). Lung cancer with dermatomyositis as the initial diagnosis: A case report.
ncbi.nlm.nih.gov/pmc/articles/PMC6535636/Zhang X, et al. (2016). Dermatomyositis as a symptom of primary lung cancer: A case report and review of the literature.
ncbi.nlm.nih.gov/pmc/articles/PMC4841099/Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. Current Version Oct 20, 2022 By Jill Seladi-Schulman, PhD Edited By Willow Banks Medically Reviewed By Adithya Cattamanchi, MD Copy Edited By Suan Pineda Share this articleMedically reviewed by Adithya Cattamanchi, M.D., Pulmonology — By Jill Seladi-Schulman, Ph.D. on October 20, 2022

related stories

Can Small Cell Lung Cancer Cause Cushing Syndrome? Paraneoplastic Syndromes and Small Cell Lung CancerUnderstanding Limited-Stage Small-Cell Lung CancerNeuroendocrine Tumors of the LungHow to Manage Refractory Small-Cell Lung Cancer

Read this next

Can Small Cell Lung Cancer Cause Cushing Syndrome? Ectopic Cushing syndrome is a potential complication of cancer, and in particular, of SCLC. Learn more about this health condition.READ MOREParaneoplastic Syndromes and Small Cell Lung CancerMedically reviewed by Adithya Cattamanchi, M.D. Paraneoplastic syndromes are a group of syndromes that develop in some people with cancer. Learn about types linked to small cell lung cancer.READ MOREUnderstanding Limited-Stage Small-Cell Lung Cancer Learn how doctors define limited-stage small-cell lung cancer as well as its symptoms, diagnosis, treatment, and outlook.READ MORENeuroendocrine Tumors of the LungMedically reviewed by Adithya Cattamanchi, M.D. Small-cell lung cancer (SCLC) is the most common type of lung neuroendocrine tumor (NET). We review what that means and discuss other types of NETs.READ MOREHow to Manage Refractory Small-Cell Lung CancerMedically reviewed by Adithya Cattamanchi, M.D. Small cell lung cancer (SCLC) is refractory if you have a relapse within 3 months and the response to further treatment is less than 10 percent.READ MOREHow Long Does Small-Cell Lung Cancer Typically Stay in Remission?Medically reviewed by Adithya Cattamanchi, M.D. Many people with small-cell lung cancer go into remission during their initial treatment. For the majority of people, small-cell lung cancer relapses…READ MORECan Lung Cancer Cause Spots on Your Skin? Some people with small cell lung cancer experience hyperpigmentation — patches of darker skin. Learn why and how it affects your treatment and outlook.READ MORESmall-Cell Lung Cancer and the COVID-19 Vaccine: Current Recommendations Individuals with lung cancer are at an increased risk of severe COVID-19. Learn about current COVID-19 vaccine recommendations for people with SCLC.READ MOREWhen Small Cell Lung Cancer Reaches Your Brain: What You Need to Know Up to 40 percent of people with small cell lung cancer have it spread to the brain. We look at how this happens, the warning signs, treatment, and…READ MORE*clone Market VIP* The 11 Best Mattresses for Lower Back Pain in 2022Medically reviewed by Gregory Minnis, DPT These 11 picks are some of the best mattresses for lower back pain. Offering medium-firm support, they’ll help keep you aligned and rested.READ MORE